- BiomeSense raises $2M in seed funding to expand its biosensor and analytics platform for daily gut microbiome tracking. - The company is working on completing its prototype biosensor and data modeling platform in preparation for the first clinical trials, scheduled for 2020.- The trials will investigate cancer progression, immunotherapy response, surgical recovery and athletic performance.BiomeSense, a Chicago, IL-based microbiome startup developing a novel biosensor and analytics platform for
Read More